According to a release, CEM is a diagnostic imaging tool used to evaluate suspicious findings from a conventional mammogram and examine potential breast cancer spread. The new measure may also ...

Roche meanwhile already has the comfort of one positive result for giredestrant from the coopERA study in post-menopausal women with hormone receptor-positive, HER2-negative early breast cancer ...

Specifically, Enhertu (trastuzumab deruxtecan) has been cleared to treat HR-positive, HER2-low metastatic breast cancer – an immunohistochemistry (IHC) score of 1+ or 2+ or negative for in situ ...

A list of all Test Kits registered with the Inferno Team can be found on the Test Kit Registry page. Licensed under the Apache License, Version 2.0 (the "License"); you may not use this file except in ...

Breast cancer is the most common cancer in women in the United States, except for skin cancers. It accounts for about 30% (or 1 in 3) of all new female cancers each year. The American Cancer Society's ...

NEW JERSEY (PIX11) — This Mother’s Day, a mother and daughter in New Jersey have a lot to be grateful for, as it’s their first Mother’s Day being cancer-free. Donna and Genna Karp-Shriber were ...

There are several different kinds of breast cancer, including multifocal, multicentric, and unifocal. Multifocal breast cancer is a type in which there is more than one tumor, either originating from ...

Breast cancer is caused by the development of malignant cells in the breast. The malignant cells originate in the lining of the milk glands or ducts of the breast (ductal epithelium). Breast ...

New episodes are released on the first Wednesday of each month. In this powerful episode, we’re joined by Bami Adenipekun, an equity consultant with lived experience of breast cancer, to discuss ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.